December 16, 2009
Novozymes to focus European activities in Switzerland and Denmark
Press Release
Novozymes will close offices in Paris and Vienna, and focus activities in Switzerland and Denmark in order to strengthen operations in Europe.
Consolidating employees in a few larger locations enables Novozymes to better respond to the complex needs of cross-regional customers, while at the same time being able to benefit from the improved critical mass in Novozymes European operations.
Fewer locations with more employees helps promote knowledge sharing and create synergy.
''By bringing the commercial functions together we can promote joint cooperation across the two European sales regions to help better meet customer needs and catch opportunities. At the same time, reducing to fewer offices ensures an efficient and cost-effective organisation,'' said Peder Holk Nielsen, Executive Vice President of Enzymes Business.
The reorganisation will result in some layoffs. The affected employees are covered by a social plan that aids them by transitioning to a new situation outside Novozymes.
It is anticipated that the majority of changes will be completed during the first half of 2010.
Novozymes is a world leader in bio-innovations with customers across a broad array of industries. The company has over 700 products used in 130 countries.










